Otarmeni FDA Approval: OTOF Gene Therapy for Hearing Loss
Examine the FDA approval of Otarmeni, the first gene therapy for OTOF-related congenital hearing loss, and its expedited National Priority Voucher review.
Back to Articles
Articles tagged with “national-priority-voucher”